MedPath

A study to establish superiority between bupivacaine with dexmedetomidine and bupivacaine with morphine when given for Trasnversus Abdominis Plane (TAP) block for pain relief after elective Caesarean sectio

Not Applicable
Completed
Conditions
Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Registration Number
CTRI/2020/08/027227
Lead Sponsor
Dewendra Gajbhiye
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

1) American Society of Anaesthesiologists (ASA) Grade II parturients 2) Minimum postoperative hospital stay of 24 hours 3) Parturients admitted for elective Caesarean section

Exclusion Criteria

1. Patient refusal 2) Allergy to study medications 3) Localized infection over injection site 4) Patients with significant coagulopathies and contraindication to regional anaesthesia 5) Patients with heart disease,altered renal or liver functions and psychological disorders 6) Patients with pregnancy induced hypertension, gestational diabetes, chronic use of pain medications and body mass index more than 35 or weight less than 50 kg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of postoperative analgesiaTimepoint: Within 24 hours postoperatively
Secondary Outcome Measures
NameTimeMethod
Haemodynamic and drug related side effectsTimepoint: Within 24 hours postoperatively;Time for first rescue analgesic requirementTimepoint: Within 24 hours postoperatively;Total analgesic requirementTimepoint: Within 24 hours postoperatively;Visual analogue scale (VAS) score at rest and movementTimepoint: Within 24 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath